(96), survivin-specific siRNA knockdown the expression of survivin by 73–88% and survivin protein expression by 52–81% in five human sarcoma cell lines regardless of the presence or absence of wild-type p53 alleles. This evidence concerns the gene TP53 and sarcoma.